In squamous cell carcinoma, nuclear focal adhesion kinase (FAK) regulates transcription of CCL5 to promote T regulatory cell recruitment and exhaustion of CD8+ T cells to promote tumor growth, and treatment with FAK inhibitors reactivates anti-tumor immune responses [65]. Here, PTK2 is linked to neoplasm.